Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This month, the Central Drugs Standard Control Organization (CDSCO) has approved Ranibizumab for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Visual Impairment Due to Diabetic Macular Oedema (DME) As diabetes and age-related eye diseases continue to rise, innovations that help preserve vision are becoming more critical than ever
Its GLP-1 program pairs FDA-approved treatments like Wegovy and Ozempic with coaching and nutrition advice
CEOs, VPs of R&D, regulatory affairs leaders, and commercial directors from biotechnology firms, CDMOs, and GLP-1 drug manufacturers comprised the supply-side sources
[Cut to Alex.] Alex, speaking: Eating better, moving more, calories in, calories out
17147429028 Address 421 N
US$ 27.49
US$ 27.72
US$ 25.33
US$ 25.42
US$ 25.50
